All News
#BestACR20Tweets
RT @RADoctor: Adjuvant #herpeszoster vaccine (Shingrix) not effective for 25% of JAKi-treated RA pts (n=40) for antibody response (T cell response usually worse, not reported). Is better than nothing good enough? Maybe we need to hold JAKi briefly?
Dr. John Cush RheumNow ( View Tweet)
New video! Risk of HCQ Retinopathy: Dr. Kathryn Dao ( @KDAO2011) #ACR20
https://t.co/7BCVvMOm0T https://t.co/DOW91SSi2u
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
"RT @drdavidliew : This - very cool.
Not as impressive as the implanted vagal stimulation pilot data, but once a day and well tolerated. Very early days but enticing, we will see!
#ACR20 ABST1995 @RheumNow https://t.co/cE3gQar0zo https://t.co/bmGnrMGaq3
Links:
Dr. John Cush RheumNow ( View Tweet)
Dr. Janet Pope ( @Janetbirdope) reviews abstract #1001 presented at #ACR20 on risk of skin cancer with methotrexate.
https://t.co/N0JelI6K5p https://t.co/n07HoO5j3y
Links:
Dr. John Cush RheumNow ( View Tweet)
Revisit our #ACR20 coverage. Listen to our Day 3 recap. Follow the link below or find us on Apple/Android podcasts.
https://t.co/IbfY5vbBAo https://t.co/YL9fAuO0oz
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @DrPetryna : #ACR20 Abs L08 Prosp. 4 year PROBE trial of Febuxostat vs allopurinol long term CV safety: febuxostat not associated w/increased risk of death compared w/allopurinol.7.2% pts died in the febuxostat group compared to 8.6% in the allopurinol group
Dr. John Cush RheumNow ( View Tweet)
SpA: Etiology to Diagnosis to Treatment - An Abstract Roundup by Dr. Robert Chao ( @doctorRBC) #ACR20
https://t.co/wR0inoR8jp https://t.co/7SFkThkPSr
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @doctorRBC : Mavrilimumab efficacious in maintaining disease remission in GCA pts.
Phase 2 trial (n=70)
Disease flare 19% in tx vs. 46% in PBO at 26wk
Sustained remission 83% vs. 50% in PBO
Similar AE in both groups Abs#L06
https://t.co/fsZxZVmDIu" https://t.co/j17naatAxX
Links:
Dr. John Cush RheumNow ( View Tweet)
Listen to our latest QD podcast on differential Dx of Arthritis in HIV+ individuals, possibilities with hyperuricemia in Psoriatic Arthritis MDA5 myositis reviewed, difficult RA with serious infections and limited options.
https://t.co/HGjgkMmOzp https://t.co/jFs8kINS3U
Links:
Dr. John Cush RheumNow ( View Tweet)
New ACR RA Guidelines and Practice Changing Abstracts #ACR20
https://t.co/3lGSUDks8F
Links:
Dr. John Cush RheumNow ( View Tweet)
Listen now! Dr. Jack Cush leads a panel of experts regarding Still's Disease and #ACR20. Download our podcasts on Apple and Android devices.
https://t.co/eV5jR0BIXO https://t.co/IChHpeiI9x
Links:
Dr. John Cush RheumNow ( View Tweet)
Listen as Dr. Petryna ( @DrPetryna) reviews several pegloticase-related abstracts presented at the #ACR20 meeting.
https://t.co/TBi1uRPXG0 https://t.co/wAUNr4mq1v
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @bella_mehta : VEXAS! Hot topic of the year #ACR2020 ABS#1953 @RheumNow https://t.co/IEC8IfE0LC https://t.co/jV3EYK0NUK
Links:
Dr. John Cush RheumNow ( View Tweet)
Long-Term Prognosis in Children with Kawasaki Disease: Dr. David Liew ( @drdavidliew) #ACR20
https://t.co/Hg8nYWcD3V https://t.co/pJIGNMnRss
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @TheLancetRheum: Results of the NOVESA phase 2 trial of Ziritaxestat in patients with diffuse cutaneous #SSc presented by @sclerodermaUM at #ACR20
Improvements in mRSS and ACR-CRISS with Ziritaxestat, but not in lung outcomes. https://t.co/GCZj64i86c https://t.co/Pd6qGEGOev
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @MGHrheumatology : Congratulations to House of DMARDs, our new @ACRheum 2020 Knowledge Bowl Champions!! 🏆 We are so proud!! @kmdsilvaMD @JonathanDauMD @NasrallahMazen #ACR20 https://t.co/wvKvCDO1m4 https://t.co/wCGG2lIqAr
Links:
Dr. John Cush RheumNow ( View Tweet)
PROs in Psoriatic Arthritis: Dr. Antoni Chan ( @synovialjoints) reviews abstract #0169 presented at #ACR20.
https://t.co/hTlrZMNnab https://t.co/HMOMnT36zf
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @Janetbirdope : Gout has more comorbidities than RA & PsA #1466 Half of respondents are correct @RheumNow @CRASCRRheum #ACR20 https://t.co/T81eo3CGjq
Links:
Dr. John Cush RheumNow ( View Tweet)
Check this out!
Can PT-CDAI in Telemedicine be Used for Care in RA? Dr. Eric Dein ( @ejdein1) #ACR20
https://t.co/dAgYOFMMJC https://t.co/QV02h171yP
Links:
Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets
RT @doctorRBC : Gender disparity in Ankylosing Spondylitis symptoms.
1⃣Women ⬆️Achilles tendonitis, plantar fasciitis, joint swelling, BASDAI>40, DMARD use
2⃣HLA-B not associated w/ enthesitis
@RheumNow #ACR20 Abs#1872 https://t.co/pBcpuqgq0K https://t.co/YWKFUdIgMl
Links:
Dr. John Cush RheumNow ( View Tweet)